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Histidyl-tRNA synthetase, anenzyme against which antibodies are directed in some patients with polymyositis, has been 
purified 5000-fold from HeLa cells, but was extremely abile to dilution or on storage at -80°C. In order to facilitate 
study of the biochemical nd immunological properties of the enzyme, a stabilizer was sought. Hemoglobin at 2 mg/ml 
was found to stimulate the enzyme and also partially preserved the activity of the enzyme stored at a low concentration 
(< I0 pg/ml). Hematin, but not the globin protein, could substitute for hemoglobin i stimulating the enzyme. 
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1. INTRODUCTION 
Hist idyl-tRNA synthetase (EC 6.1.1.21), an en- 
zyme in the family of aminoacyl - tRNA syn- 
thetases, has assumed immunological  significance 
as an autoantigen i the idiopathic in f lammatory 
myopathies (polymyositis and dermatomyosit is) 
[1]. It has been purif ied from several sources 
[2-4],  and recently we have developed a rap id  
method for obtaining the human enzyme in high 
yield (5000-fold purified) from HeLa cells for im- 
munological  studies [5]. We have found, however, 
as had been reported for the enzyme from other 
sources [3,4], that it is markedly labile to di lution 
or storage. We sought, therefore, a method to 
preserve enzymatic activity for further studies. 
Among various agents tested, hemoglobin was 
found to enhance enzyme catalysis and, further- 
more, to preserve partially the enzymatic activity 
of the preparat ion during storage at -80°C.  
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2. MATERIALS  AND METHODS 
Bovine red blood cell ubiquitin, human hemoglobin, equine 
hemin (type liD, bovine hemin (type I), human globin, salmon 
protamine sulfate, horse heart eytochrome c, and bovine serum 
albumin were from Sigma (St. Louis, MO); phenylmethylsul- 
fonyl fluoride (PMSF), 5'-adenosine triphosphate, calf liver 
tRNA and dithiothreitol (DTT) were from Boehringer Mann- 
heim Biochemicals (Indianapolis, IN); L-[3H]histidine (spec. 
act. 54.4 Ci/mmol) was from New England Nuclear (Boston, 
MA). Analytical paper discs (0.5 in) were from Schleicher and 
Schuell (Keene, NH) and 24-well microtitre plates were from 
Costar (Cambridge, MA). All other reagents were the best 
analytical grade available. Hematin was prepared by dissolving 
hemin in 0.1 N NaOH immediately before use. The final pH of 
the solution was adjusted to 8.0. All other compounds tested as 
stabilizers were dissolved in water. Histidyl-tRNA synthetase 
was prepared as described [5]. Protein was estimated by the 
BioRad protein assay procedure [6] using BSA as the standard. 
The enzyme activity was assayed using a modified method of 
Kalousek and Konigsberg [7] in a total volume of 25/zl at 37°C 
for 10 rain in 12 mM Tris-HCl buffer (pH 7.5) with 10 mM 
MgCI2, 5 mM 5'-ATP, 0.6 mM DTT, 125/~g tRNA, 5~1 L- 
[3H]histidine and an appropriate amount of enzyme protein. 
Parallel control assays were run without the enzyme in the 
presence of all the other components. Specific stabilizers were 
added to the enzyme prior to the addition of all the assay mix- 
ture components. After incubation for 10 rain the reaction was 
stopped by adding 5/~1 of cold 0.25 N HCI. An aliquot from 
each assay (25/zl) was then spotted onto analytical paper and 
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dried, and each pad was separately incubated in a well of a 
24-well microtitre plate with 10070 trichloroacetic a id at 4°C for 
20 rain. The pads were washed with triple-distilled water, dried 
at 60°C and placed in 5 ml scintillation fluid. A unit of activity 
is defined as mmol x 107 L-[3H]histidine incorporated as 
trichloroacetic acid-insoluble material in 10 min. 
3. RESULTS 
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Histidyl-tRNA synthetase was purified 
5000-fold from HeLa cells and the enzyme 
preparation, although not homogeneous, was 
found to contain no other aminoacyl-tRNA syn- 
thetase activities nor other antigens recognized by 
a variety of autoimmune s ra [5]. Because of the 
immunological importance of the enzyme as an an- 
tigen in polymyositis, we wished to pursue studies 
of the enriched enzyme. We noted, however, that 
during the course of dilution of the enzyme, its 
specific activity fell sharply at protein concentra- 
tions below 10/zg/ml, with an 80°70 drop in specific 
activity at 5/zg/ml (fig.l). Above 10/zg/ml the 
specific activity remained relatively constant. 
We attempted to restore the enzymatic activity 
by adding several substances frequently used for 
the purpose. Glycerol, glucose, BSA, protamine, 
cytochrome c and human globin, each added to a 
final concentration f 1 mg/ml, were ineffective in 
preventing the fall of histidyl-tRNA synthetase 
specific activity when the preparation was diluted 
after purification (not shown). In contrast, 
however, the addition of human hemoglobin at 
1.25 mg/ml not only partially preserved the en- 
zyme activity when the enzyme was diluted, but ac- 
tually stimulated the activity up to two-fold over a 
wide range of protein concentration (fig.l). The 
maximum stimulation occurred at a protein con- 
centration of 12.5/2g/ml with a hemoglobin con- 
centration of 1.25 mg/ml. 
Hemoglobin over the range of 0-2 mg/ml 
stimulated the enzyme activity with a maximum of 
about 6-fold stimulation of very dilute enzyme at 
2 mg/ml hemoglobin concentration (fig.2). For 
demonstration f this optimum stimulatory con- 
centration of hemoglobin, the protein concentra- 
tion used was 10/,g/ml. Above 2 mg/ml 
hemoglobin concentration there was a diminution 
of the stimulatory effect (fig.2). Although purified 
human globin protein was ineffective, freshly 
prepared hematin could substitute for hemoglobin, 
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Fig. 1. Effect of hemoglobin on enzymatic activity of histidyl- 
tRNA synthetase. Histidyl-tRNA synthetase activity was 
assayed in the absence (o) or presence (A) of 1.25 mg/ml 
hemoglobin. 
and furthermore stimulated HeLa histidyl-tRNA 
synthetase activity even more strikingly (fig.2). 
Unlike the stimulatory role of hemoglobin, where 
there was a peak for the stimulation effect, the 
hematin effect appeared to be an all-or-none 
phenomenon. Below 0.4 mg/ml it had no effect, 
but above that concentration there was a plateau 
of enzyme stimulation. At 0.4 mg/ml the molar 
concentration f hematin was 6 x 10 -4 for 5.5-fold 
stimulation of the enzyme (fig.2), and the enzyme 
concentration was approx. 1 x 10 -s M. 
The effect of hemoglobin on the stability of the 
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Fig.2. Stimulation of HeLa histidyl-tRNA synthetase using 
10/~g/ml protein concentration by hemoglobin or hematin. 
Histidyl-tRNA synthetase activity was assayed either with the 
addition of hemoglobin (o) or hematin (zx) in the amount 
indicated. 
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Table 1 
Stabilization of enzyme by hemoglobin stored at - 80°C 
Specific activity (units/mg) 
Day 0 Day 3 
Enzyme alone 12.42 0.083 
Enzyme with hemoglobin 22.77 9.911 
Diluted protein concentration for storage (at -80°C) was 
10 #g/ml. Hemoglobin concentration added to the enzyme for 
stabilization was 1.5 mg/ml prior to freezing 
enzyme stored at -80°C was then tested. When 
the enzyme was stored at 10#g/ml (protein con- 
centration) immediately after preparation (an elu- 
tion from the HPLC-DEAE column by 0-300raM 
monobasic potassium phosphate gradient), less 
than 1.0°70 of the original activity remained after 
72 h. If hemoglobin was added immediately before 
storage, 40070 of the original activity was present at 
72 h (table 1). Furthermore, when enriched HeLa 
histidyl-tRNA synthetase was stored at 20 #g/ml 
for 7 days at - 80°C in the absence of hemoglobin, 
a stimulatory effect of hemoglobin added at the 
time of assay (at 1.25 mg/ml) could be detected. 
hibit enzymatic activity at earlier steps of purifica- 
tion (unpublished). 
Stoichiometric binding of hematin to the enzyme 
is unlikely because a great molar excess of protec- 
tor to enzyme is required for the effect. However, 
previous work has indicated that oxygen radicals 
may be responsible for initiating protein damage 
[8,14,15] and hemin can markedly decrease the 
degradation of oxidatively damaged protein [9]. 
Other studies have shown that globin and 
hemoglobin could themselves be fragmented and 
aggregated by exposure to different oxygen 
radicals [8]. Together, these observations are in ac- 
cord with our findings that hematin, and to a lesser 
extent hemoglobin, but not globin itself can 
stimulate and stabilize HeLa histidyl-tRNA syn- 
thetase. This approach can be applied to stabiliza- 
tion and stimulation studies of other enzymes. 
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